NYSE: MCK | Healthcare / Medical Distribution / USA |
362.24 | -8.74 | -2.36% | Vol 1.30M | 1Y Perf 43.53% |
Feb 2nd, 2023 12:35 DELAYED |
BID | 362.21 | ASK | 362.53 | ||
Open | 376.00 | Previous Close | 370.98 | ||
Pre-Market | 379.10 | After-Market | - | ||
8.12 2.19% | - - |
Target Price | 420.82 | Analyst Rating | Strong Buy 1.54 | |
Potential % | 16.05 | Finscreener Ranking | ☆ 33.46 | |
Insiders Trans % 3/6/12 mo. | -100/-100/-100 | Value Ranking | ☆ 32.82 | |
Insiders Value % 3/6/12 mo. | -100/-100/-100 | Growth Ranking | + 32.71 | |
Insiders Shares Cnt. % 3/6/12 mo. | -100/-100/-100 | Income Ranking | + 26.54 | |
Price Range Ratio 52W % | 73.46 | Earnings Rating | Buy | |
Market Cap | 51.36B | Earnings Date | 1st Feb 2023 | |
Alpha | 0.01 | Standard Deviation | 0.07 | |
Beta | 0.63 |
Today's Price Range 355.53381.30 | 52W Range 252.82401.78 | 5 Year PE Ratio Range -6.30782.60 |
Summary:
Sell
Technical Indicators: | Sell |
Moving Averages: | Sell |
Performance | |||
---|---|---|---|
1 Week | -3.42% | ||
1 Month | -1.10% | ||
3 Months | -4.83% | ||
6 Months | 10.71% | ||
1 Year | 43.53% | ||
3 Years | 160.14% | ||
5 Years | 133.01% | ||
10 Years | 265.72% |
Mngmt Effectiveness | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
ROE (5Y Avg) | -9.10 | |||
ROE last 12 Months | -182.61 | |||
ROA (5Y Avg) | -0.78 | |||
ROA last 12 Months | 3.51 | |||
ROC (5Y Avg) | 0.43 | |||
ROC last 12 Months | -40.46 | |||
Return on invested Capital Q | -50.28 | |||
Return on invested Capital Y | -36.45 | |||
Assets Turnover | 3.40 | |||
Receivables Turnover | 11.10 |
Valuation | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
27.40 | ||||
4.92 | ||||
0.27 | ||||
12.90 | ||||
16.10 | ||||
29.90 | ||||
-4.25 | ||||
-12.46 | ||||
59.04B | ||||
Forward PE | 14.36 | |||
PEG | 2.71 |
Financial Strength | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
0.50 | ||||
1.00 | ||||
0.56 | ||||
1.64 | ||||
18.30 | ||||
Leverage Ratio | -26.90 |
Profitability | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
4.70 | ||||
1.20 | ||||
1.50 | ||||
0.70 | ||||
1.08 |
Revenue | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
203.41B | ||||
1.43K | ||||
-5.27 | ||||
5.58 |
Dividends | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
0.57 | ||||
2.16 | ||||
5.62 | ||||
9.81 | ||||
Payout ratio | 12.00 |
Earnings History | Estimate | Reported | Surprise % |
---|---|---|---|
Q03 2023 | 6.34 | 6.90 | 8.83 |
Q02 2023 | 6.13 | 6.06 | -1.14 |
Q01 2023 | 5.31 | 5.83 | 9.79 |
Q04 2022 | 6.06 | 5.83 | -3.80 |
Q03 2022 | 5.38 | 6.15 | 14.31 |
Q02 2022 | 4.67 | 6.15 | 31.69 |
Q01 2022 | 4.09 | 5.56 | 35.94 |
Q04 2021 | 5.02 | 5.05 | 0.60 |
Earnings Per End | Estimate | Revision % | Trend |
---|---|---|---|
12/2022 QR | 6.34 | 2.42 | Positive |
3/2023 QR | 6.56 | 3.47 | Positive |
3/2023 FY | 24.79 | 1.56 | Positive |
3/2024 FY | 26.37 | 1.23 | Positive |
Next Report Date | - |
Estimated EPS Next Report | 6.34 |
Estimates Count | 7 |
EPS Growth Next 5 Years % | 10.10 |
Volume Overview | |
---|---|
Volume | 1.30M |
Shares Outstanding | 141.79K |
Shares Float | 127.95M |
Trades Count | 29.47K |
Dollar Volume | 471.99M |
Avg. Volume | 991.66K |
Avg. Weekly Volume | 1.03M |
Avg. Monthly Volume | 930.16K |
Avg. Quarterly Volume | 1.02M |
McKesson Corporation (NYSE: MCK) stock closed at 370.98 per share at the end of the most recent trading day (a -2.03% change compared to the prior day closing price) with a volume of 1.66M shares and market capitalization of 51.36B. Is a component of S&P 500, Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Medical Distribution industry, Healthcare sector and employs 76000 people. McKesson Corporation CEO is Brian S. Tyler.
The one-year performance of McKesson Corporation stock is 43.53%, while year-to-date (YTD) performance is -1.1%. MCK stock has a five-year performance of 133.01%. Its 52-week range is between 252.82 and 401.78, which gives MCK stock a 52-week price range ratio of 73.46%
McKesson Corporation currently has a PE ratio of 27.40, a price-to-book (PB) ratio of 4.92, a price-to-sale (PS) ratio of 0.27, a price to cashflow ratio of 12.90, a PEG ratio of 2.32, a ROA of 3.51%, a ROC of -40.46% and a ROE of -182.61%. The company’s profit margin is 1.08%, its EBITDA margin is 1.50%, and its revenue ttm is $203.41 Billion , which makes it $1 434.57 revenue per share.
Of the last four earnings reports from McKesson Corporation, there were 2 positive earnings surprise and 2 negative earnings surprise. The company has EPS estimate of $6.34 for the next earnings report. McKesson Corporation’s next earnings report date is -.
The consensus rating of Wall Street analysts for McKesson Corporation is Strong Buy (1.54), with a target price of $420.82, which is +16.05% compared to the current price. The earnings rating for McKesson Corporation stock is Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
McKesson Corporation has a dividend yield of 0.57% with a dividend per share of $2.16 and a payout ratio of 12.00%.
McKesson Corporation has a Sell technical analysis rating based on Technical Indicators (ADX : 7.69, ATR14 : 6.83, CCI20 : -130.06, Chaikin Money Flow : -0.06, MACD : -0.34, Money Flow Index : 30.58, ROC : -2.84, RSI : 40.85, STOCH (14,3) : 13.37, STOCH RSI : 0.00, UO : 46.59, Williams %R : -86.63), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of McKesson Corporation in the last 12-months were: Brian S. Tyler (Option Excercise at a value of $6 640 050), Brian S. Tyler (Sold 43 204 shares of value $13 924 028 ), Britt Vitalone (Option Excercise at a value of $2 471 827), Britt Vitalone (Sold 33 234 shares of value $11 015 602 ), Kevin W. Emerson (Sold 25 shares of value $6 404 ), Lori A. Schechter (Option Excercise at a value of $-792 632), Lori A. Schechter (Sold 47 507 shares of value $16 112 866 ), Nancy Flores (Option Excercise at a value of $0), Nancy Flores (Sold 5 359 shares of value $1 712 018 ), Thomas L. Rodgers (Option Excercise at a value of $0), Thomas L. Rodgers (Sold 2 196 shares of value $770 375 ), Tracy Faber (Option Excercise at a value of $483 807), Tracy Faber (Sold 13 631 shares of value $4 376 919 ), Tracy L. Faber (Option Excercise at a value of $2 168 962), Tracy L. Faber (Sold 24 364 shares of value $8 579 763 )
Analyst Ratings | Current | 1 M ago | 3 M ago |
---|---|---|---|
Strong Buy | |||
Moderate Buy | |||
Hold | |||
Moderate Sell | |||
Strong Sell | |||
Summary Rating | Strong Buy | Strong Buy | Strong Buy |
McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. Outside the U.S. market, McKesson engages in pharmaceutical wholesale and distribution in Europe and Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
CEO: Brian S. Tyler
Telephone: +1 972 446-4800
Address: 6555 State Highway 161, Irving 75039, TX, US
Number of employees: 76 000
Wed, 27 Jul 2022 09:31 GMT Deutsche Bank Believes McKesson (MCK) Wont Stop Here
- TipRanks. All rights reserved.Copyright © 2016-2023 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
All rights reserved. Financial Market Data powered by Quotemedia.com. All rights reserved. View the Terms of Use. CBOE EDGX Top real-time data for Premium users, NYSE/NYSE MKT (AMEX) data delayed 20 minutes. NASDAQ and other data delayed 15 minutes unless otherwise indicated. Technology and data provided by TeleTrader. Conditions of Use. The regulations of the respective stock are to be observed. Copyright © 2023. All market data is provided by Quotemedia.com. Futures: at least a 10 minute delay. Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. To see all exchange delays and terms of use, please see disclaimer. The Cryptocurrency Market real-time data provided by Cryptocompare.com
Don´t have an account? Register
Looks like you are using AdBlock.
The revenue earned from advertising enables us to provide the quality content you are trying to reach on this website. In order to view this page, please disable AdBlock or purchase Premium.
Sign in if you already have Premium account.
This could take some time, please wait.